EUVIMEDOpdag EUVIMED
Open access · CC BY 4.0

PIK ‐ III ‐Mediated Elevation of Thiamine Re‐Sensitises Renal Cell Carcinoma to Cuproptosis via Activating PDHA1

Dongdong Xie iD, Yu Wang, Wenjie Cheng, Minbo Yan, Kunyu Li, Xiang Wu, Jiaqing Wu, Zhuangzhuang Zhang, Yingbo Dai iD

Cell Proliferation · 2026-03 · 59 (3)

DOI: 10.1111/cpr.70101 ↗

At a glance

Journal article in Cell Proliferation, published online on 2025-07-31. Written by Dongdong Xie and 8 co-authors. Institution: Department of Urology, The Fifth Affiliated Hospital of Sun Yat-sen University, Zhuhai, China. Major MEDLINE topics: Carcinoma, Renal Cell, Cuproptosis, Thiamine, Hydrazines. Cited 8 times so far (Crossref); 51 references. The full text is freely available (open access, CC BY 4.0). Funded by: Natural Science Foundation of Guangdong Province, National Natural Science Foundation of China.

AbstractSubjectsBibliografiske oplysningerCiteRelated studies

Abstract (original language)

Cuproptosis, a copper‐dependent cell death mechanism driven by tricarboxylic acid (TCA) cycle collapse, shows limited efficacy in hypoxic or glycolytic renal cell carcinoma (RCC). Here, through systematic screening of 688 glycolysis inhibitors combined with elesclomol (ES), we identified PIK‐III as a potent cuproptosis sensitiser. Multi‐omics analysis revealed that PIK‐III restores sensitivity by rewiring thiamine metabolism. Mechanistically, PIK‐III induces macropinocytosis, enabling thiamine uptake to replenish thiamine pyrophosphate (TPP), which activates pyruvate dehydrogenase E1‐alpha 1 (PDHA1) and redirects pyruvate into the TCA cycle. Concurrently, ES‐induced DLAT oligomerisation disrupts TCA flux, creating a metabolic crisis. In vivo, PIK‐III synergises with ES to suppress tumour growth in xenograft and patient‐derived models without systemic toxicity. Our work uncovers a metabolic vulnerability in cuproptosis‐resistant RCC and positions PIK‐III as a therapeutic candidate to overcome resistance via dual targeting of thiamine transport and mitochondrial dysfunction.

Subjects

MeSH terms (MEDLINE)

Carcinoma, Renal CellCuproptosisThiamineHydrazinesGlycolysisMultiomicsPinocytosisPyruvate Dehydrogenase (Lipoamide)Citric Acid CycleHumansAnimalsXenograft Model Antitumor AssaysCell Line, TumorMice, Inbred BALB CAntineoplastic AgentsOxidative Stress

Author keywords

PIK‐IIIWarburg effectccRCCcuproptosisthiamine metabolism

Substances

Thiaminepyruvate dehydrogenase E1alpha subunitPyruvate Dehydrogenase (Lipoamide)elesclomolHydrazinesAntineoplastic Agents

Authors and institutions

  • Department of Urology, The Fifth Affiliated Hospital of Sun Yat-sen University, Zhuhai, China.
  • Guangdong Provincial Engineering Research Center of Molecular Imaging, The Fifth Affiliated Hospital, Sun Yat-sen University, Zhuhai, China.
  • Guangdong-Hong Kong-Macao University Joint Laboratory of Interventional Medicine, The Fifth Affiliated Hospital, Sun Yat-sen University, Zhuhai, China.
  • Department of Kidney Transplantation, The Third Affiliated Hospital of Sun Yat-sen University, Guangzhou, China.

ORCID profiles: Dongdong Xie, Yingbo Dai

Funding

  • Natural Science Foundation of Guangdong Province
  • National Natural Science Foundation of China

Cite

APA

Xie, D., Wang, Y., Cheng, W., Yan, M., Li, K., Wu, X., Wu, J., Zhang, Z., & Dai, Y. (2026). PIK ‐ III ‐Mediated Elevation of Thiamine Re‐Sensitises Renal Cell Carcinoma to Cuproptosis via Activating PDHA1. Cell Proliferation, 59(3). https://doi.org/10.1111/cpr.70101

Vancouver

Xie D, Wang Y, Cheng W, Yan M, Li K, Wu X, et al. PIK ‐ III ‐Mediated Elevation of Thiamine Re‐Sensitises Renal Cell Carcinoma to Cuproptosis via Activating PDHA1. Cell Proliferation. 2026;59(3). doi:10.1111/cpr.70101

BibTeX
@article{Xie2026,
  author = {Xie, Dongdong and Wang, Yu and Cheng, Wenjie and Yan, Minbo and Li, Kunyu and Wu, Xiang and Wu, Jiaqing and Zhang, Zhuangzhuang and Dai, Yingbo},
  title = {PIK ‐ III ‐Mediated Elevation of Thiamine Re‐Sensitises Renal Cell Carcinoma to Cuproptosis via Activating PDHA1},
  journal = {Cell Proliferation},
  year = {2026},
  volume = {59},
  number = {3},
  doi = {10.1111/cpr.70101}
}
Start for free →